glp-1 obesity drug news october 21 2025 Weight-loss drugs such as Ozempic were in the headlines a lot in – and patent protections for these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @ Outlook for obesity in 2025:

The Panel can say that it considers that the circumstances of this case, the length of hearings and the allegations made at various stages of those hearings, as well as the way in which the case was conducted by USADA and the evidence was presented and, in some cases, later abandoned, seems to be out of proportion to the severity and consequences of the ADRVs that have been established , reads its Decision

1):Abstract 520-P

Hesham Atwa or one of his excellent colleagues at Long Island Laparoscopic Doctors about your best next step

Elevated levels of NNMT activity is associated with reduced cellular energy expenditure and increased fat storage